NCT00689754 Efficacy and Safety Study on Nasogastric (NG) Tube in Patients With Upper Gastrointestinal Bleed Status COMPLETED Phase NA
NCT00687219 Efficacy and Safety of Peginterferon Alfa-2b and Ribavirin Therapy in Subjects With Type C Compensated Liver Cirrhosis (Study P05116) Status COMPLETED Phase PHASE3
NCT00679692 Evaluation the Growth Factors(IGF-1,IGFBP-3and HGH)in Patients With Chronic Liver Disease Status COMPLETED Phase N/A
NCT00678613 Role of Probiotics in the Prevention of Spontaneous Bacterial Peritonitis in Cirrhotic Patients: A Randomized Placebo Control Trial Status UNKNOWN Phase PHASE2/PHASE3
NCT00592475 A Study to Assess the Safety and Effects of Intravenous (IV) Conivaptan on the Hepatic Hemodynamic Response in Cirrhotic Patients Status COMPLETED Phase PHASE2
NCT00562783 A Phase II, Double-blinded, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Vitalliver in Patients With Decompensated Cirrhosis Status COMPLETED Phase PHASE2
NCT00540397 TCM Etiological Study on the Theory of XuSunShengJi in Liver Cirrhosis Status UNKNOWN Phase NA
NCT00501722 Satavaptan Dose-Ranging Study in Hyponatraemic Patients With Cirrhotic Ascites Status COMPLETED Phase PHASE2
NCT00501566 Satavaptan Dose-Ranging Study in Normonatraemic Patients With Cirrhotic Ascites Status COMPLETED Phase PHASE2
NCT00488917 Sepsis, Endothelial Function, and Lipids in Critically Ill Patients With Liver Failure (the SELLIFA Study) Status COMPLETED Phase N/A
NCT00470340 Chemotherapy or Not, Following Complete Treatment of Hepatic Cancer in Cirrhotic Patients Status TERMINATED Phase PHASE3
NCT00469131 Effects of Immunosuppression on HCV Recurrence After Living Donor Liver Transplantation - Comparative Study Between Tacrolimus + MMF and Tacrolimus + Steroid Status COMPLETED Phase PHASE3
NCT00382278 Safety Study of Autologous Stem Cell in Liver Cirrhosis Status TERMINATED Phase PHASE1/PHASE2
NCT00381017 Effects of Low-dose Maintenance Peg Interferon Alfa-2b Therapy Versus Supportive Care in Patients With Cirrhotic Hepatitis C With HIV (Study P04371) Status WITHDRAWN Phase PHASE3
NCT00378599 Effects of Pegylated Interferon Alfa-2b and Ribavirin After Orthotopic Liver Transplantation in Subjects With Chronic Hepatitis C Recurrence (P04590AM3)(COMPLETED) Status COMPLETED Phase PHASE3
NCT00366795 Satavaptan for the Prevention of Ascites Recurrence in Patients With Ascites Due to Cirrhosis of the Liver Status TERMINATED Phase PHASE3
NCT00359437 Satavaptan in the Prevention of Ascites Recurrence in Patients With Ascites Due to Cirrhosis of the Liver Status TERMINATED Phase PHASE3